甘李药业：公司高度关注资本市场的反馈

Core Viewpoint - The company acknowledges the feedback from the capital market and understands investors' concerns regarding its long-term value, emphasizing that short-term stock price fluctuations do not fully reflect its operational quality and growth potential [1] Group 1: Company Strategy - The company plans to enhance its independent research and development capabilities and international expansion efforts [1] - It aims to strengthen its research and development across the entire field of diabetes diagnosis and treatment while also exploring other research pipelines [1] - The company is focused on continuously increasing its intrinsic value [1]